Skin care products for mild to moderate acne
Part of Skin clinical trials.
This study tests a new set of skin care products (a cleanser, a combination cream, and a spot cream) to see how well they work and if they are safe for people with mild to moderate acne. If you join, you will use these products as directed, and the researchers will check how your skin improves.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 15 and 50 years old.
- Your acne is mild to moderate (not severe).
- You are willing to stay in the study until it ends.
- You are not allergic to skin care products.
- You have not used other acne treatments or procedures in the last month.
- If you are female, you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares three different gels for treating mild to moderate acne on the face. One gel contains standard acne medication, another adds a steroid, and the third uses a special ingredient from stem cells (called secretome) to see which works best and is safest.
This trial tests a cream called KR230109 for mild to moderate facial acne. The goal is to see if the cream is safe and helps reduce pimples and blackheads/whiteheads. You will be asked to use the cream as directed and attend study visits.
This trial compares two topical creams, clascoterone and adapalene, to see which works better for mild acne. If you have mild acne and are between 12 and 35, you might be able to join.
This trial is testing a new spray called B244 that you put on your face to help treat moderate to severe acne. It aims to see if it is safe, works well, and is comfortable to use.
This trial tests a new combination hormonal pill (a progestogen and low-dose estrogen) to treat moderate acne in women. It may be an option if you have not had success with other acne treatments.
This study tests a new medication called HB0043 for people with mild to moderate facial acne. It aims to see if the treatment is safe and effective in reducing acne.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.